Neflamapimod Shows Promise in Dementia With Lewy Bodies

(MedPage Today) — New data from a phase IIb trial extension study suggested that investigational neflamapimod led to significant improvements on key outcomes in people with dementia with Lewy bodies (DLB).
In the RewinD-LB extension study, neflamapimod…